Results 111 to 120 of about 949,112 (257)
SUBSTANCE ABUSE TREATMENT: WHAT DO WE KNOW? AN ECONOMIST’S PERSPECTIVE [PDF]
The substance abuse treatment literature has basically dealt with four important questions: 1) Is treatment effective? 2) Are all programs equally effective? 3) why do programs differ in their effectiveness?
Matilde P. Machado
core
Competencies for Canada’s substance abuse workforce. [PDF]
, 2010 This report forms a supportive resource that identifies the technical and behavioural competencies required to perform effectively in the substance abuse field (from health promotion, support and outreach, counselling, withdrawal management, and ...
core
, 2010 Li-Tzy Wu*Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Duke University Medical Center, Durham, NC, USA *Li-Tzy Wu is the Editor-in-Chief of Substance Abuse and RehabilitationAbstract: Alcohol, tobacco, and illegal
Li-Tzy Wu, Wu, Li-Tzy
core +1 more source
Peptide‐directed nanovehicles enabling tumor‐selective ROS amplification and antitumor immunity
VIEW, EarlyView.Cancer cells are vulnerable to oxidative stress, yet exploit immune tolerance to escape destruction. In contrast, their metabolic profile is markedly altered to support rapid proliferation, accompanied by elevated production of reactive oxygen species (ROS).
Manuela Calin +3 more
wiley +1 more source
Periodontology 2000, EarlyView., 2023 Abstract This narrative review celebrates Europe's contribution to the current knowledge on systemically administered antimicrobials in periodontal treatment. Periodontitis is the most frequent chronic noncommunicable human disease. It is caused by dysbiotic bacterial biofilms and is commonly treated with subgingival instrumentation.
David Herrera +4 more
wiley +1 more source
Protodesnitazene: The identification and tissue distribution of a new nitazene
Journal of Forensic Sciences, EarlyView.Abstract Multiple new analogues from the 2‐benzyl benzimidazole or “nitazene” class of drugs have emerged on the drug market in recent years. Nitazenes are highly potent μ‐opioid receptor agonists that present a substantial public health concern due to their elevated risk of severe toxicity in overdose and their significant potential for misuse.
Andrew Griffiths +4 more
wiley +1 more source
Intravenous tapentadol abuse in treatment-seeking youngrural adults: a case series
Indian Journal of Mental Health and NeurosciencesBackground: Tapentadol is a centrally acting opioid analgesic with m-opioid receptor agonism and norepinephrine reuptake inhibition. Although approved for the management of moderate to severe pain, emerging reports suggest increasing misuse of ...
Rajalakshmi Arunachalam +2 more
doaj +1 more source
Treating adolescent substance abuse: state of the science
, 2006 In October, 2001, just a month after the World Trade Center tragedy, a 2-day conference was scheduled to be held in Coral Gables, Florida entitled Treating Adolescent Substance Abuse: State of the Science funded by the National Institute on Drug Abuse ...
Rowe, Cynthia L., Liddle, Howard A.
core +1 more source
Acta Psychiatrica Scandinavica, EarlyView.ABSTRACT Introduction Understanding the differences in treatment response between subtypes of major depressive disorder (MDD) may help to prevent lengthy trial‐and‐error processes by identifying effective treatment options. The aim of the study was to investigate the impact of atypical features of MDD (MDD‐A) on the response to lithium augmentation (LA)
Hannah Buchbauer +8 more
wiley +1 more source
Executive function and adult homelessness, true impairment or frontal lobology?
Frontiers in Human NeuroscienceHomelessness is associated with multiple risk factors for neurocognitive impairment. Past research with people experiencing homelessness has described “frontal lobe” dysfunction including behavioral disorders and executive cognitive impairments.
Graham Pluck, Graham Pluck
doaj +1 more source